Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on social injustice Commitment to include partnerships and support to address the underrepresentation of minorities, including African American/Black and Hispanic communities, in clinical trials Reinforces US […]
Other News
JanOne Announces Strategic Plan to Divest its Legacy Businesses
Update on plans for sale of recycling business. Divesting will allow for focus on core life science assets LAS VEGAS, Sept. 16, 2020 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, provided an update today regarding its initiatives […]
DiNAQOR AG Appoints Eduard Ayuso as Chief Technology Officer
Company Also Expands Advisory and Leadership Teams with New Member of Scientific Advisory Board, Chairman of DiNAQOR UK, and General Counsel PFÄFFIKON, Switzerland, Sept. 16, 2020 /PRNewswire/ — DiNAQOR AG, a gene therapy platform company, today announced that Eduard Ayuso, D.V.M., Ph.D. has been appointed as Chief Technology Officer. The Company also announced the addition of Mauro Giacca, […]
CoreMap Completes $10.5 Million Series A Financing
Round led by Qure Ventures Will Accelerate Development of CoreMap’s Technology to Enable Curative, Patient-Specific Treatment of Atrial Fibrillation BURLINGTON, Vt., Sept. 16, 2020 (GLOBE NEWSWIRE) — CoreMap announced today it has completed a $10.5 million Series A financing led by Qure Ventures. The round included both existing investors such […]
VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study
Study will evaluate the impact of remote patient monitoring on clinical outcomes, readmission rates, and patient satisfaction following a transcatheter aortic valve replacement procedure SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today that it has begun the TELESTAR-TAVR clinical study (Deployment of Telemedicine […]
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH)
CAMBRIDGE, Mass. & PARMA, Italy–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients and Chiesi Farmaceutici S.p.A., an international research-focused healthcare group (Chiesi Group), today announced a collaboration aimed at the discovery and development […]
Corventive Health to Deliver American College of Cardiology’s Evidence-Based Content in its Innovative Cardiac Care Solutions
Corventive Now Delivers Evidence-Based Content to Enhance Patient Care. NEWTOWN, Pa., Sept. 15, 2020 /PRNewswire/ — Corventive Health, a provider of cloud-based and AI technology solutions, announced its plan to integrate American College of Cardiology (“ACC”) evidence-based content into its innovative cardiac solutions. Incorporating ACC clinical content enables Corventive to deliver insights designed […]
LindaCare Appoints Deyo to Chairman and CEO of LindaCare NV
LEUVEN, Belgium and STAMFORD, Conn., Sept. 15, 2020 /PRNewswire/ — LindaCare announces the appointment of Donald Deyo to Chairman and Chief Executive Officer of the LindaCare NV. Deyo has served as Chairman of the Board for the Company since 2017. LindaCare is a digital health company specializing in integrated remote cardiac monitoring software and services. The […]
US FDA grants Fast Track designation to Jardiance® (empagliflozin) to improve outcomes following a heart attack
– FDA Fast Track designation facilitates the development of potential new therapies that treat serious conditions and fulfill an unmet medical need – This Fast Track designation for empagliflozin emphasizes the urgent need for potential treatments that may improve outcomes following an acute myocardial infarction, more commonly known as a […]
BioSig Releases PURE EP Study Abstract with Data Presented at European Society of Cardiology’s ‘ESC Congress 2020’
Positive responses confirm that the PURE EP signals are preferred to conventional sources of intracardiac signals in a blinded, independent analysis. Abstract concludes PURE EP™ System is able to produce reliable and high-quality signals when compared to the available standard of care systems. Westport, CT, Sept. 15, 2020 (GLOBE NEWSWIRE) […]
Recent
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
Popular
- No commented posts yet